MedImmune Acquires Spirogen and Invests in ADC Therapeutics

News   Oct 15, 2013

 
MedImmune Acquires Spirogen and Invests in ADC Therapeutics
 
 
 
FURTHER INFORMATION
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE